Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Net Margin (2017 - 2020)

Cogent Biosciences has reported Net Margin over the past 4 years, most recently at 18325.64% for Q3 2020.

  • Quarterly results put Net Margin at 18325.64% for Q3 2020, down 1715672.0% from a year ago — trailing twelve months through Jun 2021 was 31541.03% (down 3144416.0% YoY), and the annual figure for FY2025 was 10507.38%, changed.
  • Net Margin for Q3 2020 was 18325.64% at Cogent Biosciences, down from 1401.52% in the prior quarter.
  • Over the last five years, Net Margin for COGT hit a ceiling of 15.02% in Q4 2019 and a floor of 18325.64% in Q3 2020.
  • Median Net Margin over the past 4 years was 325.94% (2017), compared with a mean of 1632.07%.
  • Peak annual rise in Net Margin hit 29626bps in 2020, while the deepest fall reached -1715672bps in 2020.
  • Cogent Biosciences' Net Margin stood at 315.87% in 2017, then rose by 28bps to 226.18% in 2018, then soared by 107bps to 15.02% in 2019, then plummeted by -122069bps to 18325.64% in 2020.
  • The last three reported values for Net Margin were 18325.64% (Q3 2020), 1401.52% (Q2 2020), and 86.67% (Q1 2020) per Business Quant data.